• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Center for RNA Biomedicine

Ann Arbor, MI

MembershipGive online

MENUMENU
  • Home
  • About
    • About RNA
    • Mission
    • Become a Member
    • History
    • Financial Support
    • Diversity, Equity & Inclusion
  • Research
    • Core Facilities
      • Bru-Seq Lab
      • Single Molecule Analysis in RT
    • Scientific Articles
    • Scientific Articles Highlights
    • Pilot Grants (2017–18)
  • People
    • U-M Faculty Members
    • RNA Faculty Scholars
    • Faculty Testimonials
    • Featured Researchers
    • Leadership and Staff
      • Directors
      • Executive Committee
      • Strategic Advisory Board
      • Student & PostDoc Council
      • Staff
  • Resources
    • Grant Sprints
    • Grant Proposal Support
    • Recruitment Opportunities
    • Publication Support
    • RNA Skills
      • RNA Skill Share
      • Technique Demo Videos
    • U-M RNA Resources
      • U-M Research Cores
      • RNA courses at U-M
      • U-M Depts & Centers
    • Non U-M RNA Partners
  • Events
    • Calendar
    • Symposia
      • 2022 Symposium
      • 2021 Symposium
      • 2020 Symposium
      • 2019 Symposium
      • 2018 Symposium
      • 2017 Symposium
      • 2016 Inaugural Symposium
    • RNA Innovation Seminars
      • 2021-2022 Seminars
      • 2020-2021 Seminars
      • 2019-2020 Seminars
      • 2018-2019 RNA Seminars
      • 2017-2018 RNA Seminars
      • 2016-2017 RNA Seminars
      • 2015-2016 RNA Seminars
    • RNA Collaborative Seminar Series
  • News
    • In the Media
  • Our Publications
    • Weekly News
      • Weekly News Archive
    • Magazine and Report
      • RNA Translated 2021, “RNA Therapeutics”
      • RNA Translated 2020, “The Year of the RNA Virus”
    • Center’s Brochure
    • Join our Mailing List
  • Giving
  • Contact

COVID-19 vaccine

RNA Innovation Seminar: Melissa J. Moore – Chief Scientific Officer, Moderna Therapeutics

03/03/2021

This event was rescheduled from February 10, 4:00 pm.
To attend on March 3rd, please register again. Apologies for the inconvenience. 

ZOOM REGISTRATION REQUIRED

“A timely confluence: The backstory of Moderna’s COVID-19 vaccine”


Melissa Moore, Ph.D.,
Chief Scientific Officer, Moderna Therapeutics

Dr. Moore will address scientists and non-scientists, and will take live questions. 

FLYER IN PDF

In her role as Chief Scientific Officer, Platform Research, Dr. Melissa Moore is responsible for leading mRNA biology, delivery and computation science research at Moderna. She joined Moderna in 2016 from the University of Massachusetts Medical School, where she served as Professor of Biochemistry & Molecular Pharmacology, Eleanor Eustis Farrington Chair in Cancer Research and a long-time Investigator at the Howard Hughes Medical Institute (HHMI).  Dr. Moore was also a founding Co-Director of the RNA Therapeutics Institute (RTI) at UMassMed, and was instrumental in creating the Massachusetts Therapeutic and Entrepreneurship Realization initiative (MassTERi), a faculty-led program intended to facilitate the translation of UMMS discoveries into drugs, products, technologies and companies.  Dr. Moore is an elected member of the National Academy of Sciences (2017) and a Fellow of the American Academy of Arts and Sciences (2019).

Dr. Moore holds a B.S. in Chemistry and Biology from the College of William and Mary, and a Ph.D. in Biological Chemistry from MIT, where she specialized in enzymology under Prof. Christopher T. Walsh.  She began working on RNA metabolism during her postdoctoral training with Phillip A. Sharp at MIT.  During her 23 years as a faculty member, first at Brandeis and then at UMassMed, her research encompassed a broad array of topics related to the roles of RNA and RNA-protein (RNP) complexes in gene expression, and touched on many human diseases including cancer, neurodegeneration, and preeclampsia.

Tagged With: COVID-19 vaccine

Footer

Copyright © 2022 University of Michigan Board of Regents